Skip to content

Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms

Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04637230
Acronym
PRICE
Enrollment
10000
Registered
2020-11-19
Start date
2021-10-01
Completion date
2023-06-30
Last updated
2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Atrial Premature Complexes, Sinus Rhythm, Ventricular Premature Complexes, Ventricular Tachycardia, Nonsustained

Keywords

Automated ECG diagnosis

Brief summary

Single-channel electrocardiograms (lead I of 12-lead surface ECG; 30 seconds) will be collected from subjects/patients at 11 clinical centers in Germany to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms. Heart rhythms of interest are normal sinus rhythm (SR), atrial fibrillation (AF), atrial premature beats (APBs), ventricular premature beats (VPBs), and nonsustained ventricular tachycardia (VT). Per diagnosis, 20,000 ECGs are required, for a total of 100,000 ECGs to be obtained from approximately 10,000 subjects/patients.

Detailed description

In phase 1 of a research project titled 'Prevention of stroke and sudden cardiac death by Recording of 1-Channel Electrocardiograms' (PRICE), a total of 100,000 30-sec single-channel ECGs (lead I of 12-lead surface ECG) will be collected from approximately 10,000 subjects/patients at 11 participating clinical centers in Germany. Relevant baseline clinical patient characteristics will also be recorded. The ECGs, diagnosed by an experienced electrophysiologist (diagnostic gold standard), will be fed into an Artificial Intelligence (AI) for the automatic detection of normal sinus rhythm (SR), atrial fibrillation (AF), atrial premature beats (APBs), ventricular premature beats (VPBs), and nonsustained ventricular tachycardia (VT). It is expected that the overall diagnostic accuracy of the AI against an experienced electrophysiologist will be on the order of 95%. In PRICE phase 2, ECG diagnosis by the AI will be compared with the diagnosis by 3 general cardiologists of the same ECGs. It is expected that the AI will surpass the general cardiologists in terms of diagnostic accuracy. The final clinical phase of the PRICE project will comprise a randomized controlled community trial of risk patients to establish the superiority in stroke prevention of AI detection of AF on smart-watch ECGs vs. no AF detection.

Interventions

DIAGNOSTIC_TESTElectrocardiogram analysis by Artificial Intelligence

1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms

Sponsors

A-Rhythmik GmbH
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Heart rhythm of interest present on ECG

Exclusion criteria

* Patient incapable of or not willing to sign informed consent form

Design outcomes

Primary

MeasureTime frameDescription
ECG T wave inversionImmediateAssessment of presence (Yes) or absence (No) of T wave inversion
ECG QRS-complex durationImmediateMeasurement of width/duration of QRS complex; distinction between narrow (\<=110ms) and wide (\>110ms)
ECG QRS-complex fragmentationImmediateAssessment of presence (Yes) or absence (No) of QRS-complex fragmentation
ECG QTc intervalImmediateCalculation of heart rate corrected QT interval (QTc) via Bazett formula from measured QT interval
Diagnostic accuracy of AI1 yearOverall diagnostic accuracy of the AI in the diagnosis of normal SR, AF, APBs, VPBs, and nonsustained VT (gold standard: diagnosis by experienced electrophysiologist)
ECG R-R intervalImmediate30-sec mean and standard deviation of R-R intervals

Secondary

MeasureTime frameDescription
ECG PQ intervalImmediateMeasurement of PQ interval (onset of P wave to onset of Q wave) on ECG
ECG QT intervalImmediateMeasurement of QT interval (onset of Q wave to end of T wave) on ECG
ECG P waveImmediateAssessment of presence (Yes) or absence (No) of P wave on ECG; measurement of P-wave duration (in ms)

Countries

Germany

Contacts

Primary ContactKarl-Heinz Kuck, MD
karl-heinz.kuck@uksh.de+49451 500 75301
Backup ContactMichael Schlüter, PhD
meos04@gmx.de+49172 4089325

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026